|
NEDD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.589800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.036800E-01 |
| Normal-vs-Stage2 |
4.102400E-01 |
| Normal-vs-Stage3 |
3.399400E-01 |
| Normal-vs-Stage4 |
4.868600E-01 |
| Stage1-vs-Stage2 |
7.305800E-01 |
| Stage1-vs-Stage3 |
4.542100E-02 |
| Stage1-vs-Stage4 |
1.360180E-01 |
| Stage2-vs-Stage3 |
1.349620E-01 |
| Stage2-vs-Stage4 |
1.970200E-01 |
| Stage3-vs-Stage4 |
8.978400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.118000E-01 |
| Normal-vs-AfricanAmerican |
5.111200E-01 |
| Normal-vs-Asian |
4.923600E-01 |
| Caucasian-vs-AfricanAmerican |
5.132800E-01 |
| Caucasian-vs-Asian |
3.779800E-01 |
| AfricanAmerican-vs-Asian |
9.855200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.576600E-01 |
| Normal-vs-Female |
6.683600E-01 |
| Male-vs-Female |
6.122200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.803000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.175000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.822800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.967600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.821770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.870000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.718400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.897200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.169000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.941400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.127570E-02 |
| Classical-VS-Follicular |
1.715360E-01 |
| Classical-VS-Other |
7.864800E-01 |
| Classical-VS-Normal |
2.903400E-01 |
| Tall-VS-Follicular |
3.498200E-01 |
| Tall-VS-Other |
4.026400E-01 |
| Tall-VS-Normal |
2.073000E-01 |
| Follicular-VS-Other |
8.571200E-01 |
| Follicular-VS-Normal |
7.495400E-01 |
| Other-VS-Normal |
9.368200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.744200E-01 |
| Normal-vs-N1 |
5.791200E-01 |
| N0-vs-N1 |
6.503600E-01 |
|
|
